Kamari Pharma

Small Molecule Inhibitors of TRPV3

Health Tech & Life Sciences
Active
Series A Ness Ziona, Israel Founded 2018
Last updated 2026-06-18
Total raised
$31.0M
Last: 2025-06
Stage
Series A
Founded
2018
Headcount
9
HQ
Ness Ziona, Israel
Sector
Health Tech & Life Sciences

About

Kamari Pharma is a biopharmaceutical company aiming to develop and commercialize proprietary small molecule inhibitors of TRPV3, a cation channel expressed primary in keratinocytes, for the treatment of dermatological conditions with unmet need. TRPV3 has been extensively evaluated as a target for drug development, identified as the cause of Olmsted syndrome in humans, and shows involvement in various skin disorders including keratoderma, atopic dermatitis, psoriasis, rosacea, and post-burn pruritus.

Funding history · 3 rounds · $31.0M total

Q&A

What is Kamari Pharma's primary focus?
Kamari Pharma is a biopharmaceutical company focused on developing and commercializing proprietary small molecule inhibitors of TRPV3 for the treatment of dermatological conditions.
When was Kamari Pharma founded?
Kamari Pharma was founded in October 2018.
What is Kamari Pharma's employee count?
Kamari Pharma has 1-10 employees.
What is the total funding raised by Kamari Pharma to date?
Kamari Pharma has raised a total of $31,000,000 USD.
Which investors participated in Kamari Pharma's funding round in September 2022?
Guangzhou Sino-Israel Biotech Investment Fund (GIBF) participated in Kamari Pharma's $8,000,000 funding round in September 2022.
Which investors led Kamari Pharma's most recent funding round in June 2025?
Pontifax and BRM Group led Kamari Pharma's $23,000,000 funding round in June 2025.
What is the current stage of Kamari Pharma's product development?
Kamari Pharma's product is currently in the R&D stage.
Does Kamari Pharma hold any patents?
Yes, Kamari Pharma holds 1 patent.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B

Highlights

1 PatentsVerified

Tags

biopharmaceuticaldrug-developmentdermatologypharma-companiesskinrare-diseasespharmaceuticals
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)